Small intestinal bacterial overgrowth (SIBO) is characterized by an overpopulation (in excess of 105– 106) of bacteria in the small intestine and stomach (Khalighi et al., 2014; Nabanan & Fauzi, 2015). Several urinary organic acid biomarkers are available which help determine the presence and overpopulation of such bacterial species. Such knowledge is critical as it […]
Read MoreGut dysbiosis is a condition characterized by a disruption in the ratio and number of microorganisms (known as the microbiome) in the small and large intestine to include bacteria, parasites, viruses, and fungus (Huang, Gao, Yu, Zhu, Ding, & Qin, 2019). Such aberrations in gut function are linked to altered nutrient digestion/absorption, reduced immune/barrier function, […]
Read MoreFat is a macronutrient necessary for several key physiological roles in the body. Specifically, fatty acids (carbon bonds ranging from 4-24 with a carboxyl group) which form fats, is a large energy source and provider of cell membrane constituents (Calder, 2015; Lord & Bralley, 2012). Fatty acids (FAs) also have biological roles that include tissue […]
Read MoreIn my last post, I outlined possible causes of metabolic syndrome (MS) as well as pathophysiological manifestations of said condition, to include dysregulation of fatty acid synthesis (dyslipidemia). One cause of dyslipidemia includes an overabundance of insulin production, which is also a marker of MS (Lord & Bralley, 2012). However, it is also possible that […]
Read MoreInsulin resistance (IR) can be thought of as an early biomarker in the development type 2 diabetes (T2D). Such a condition presents as higher than normal levels of insulin required to dispose of blood glucose (Lord & Bralley, 2012). Generally, if fasting serum insulin levels are above 10IU/mL, such a condition may indicate the beginnings […]
Read MoreMetabolic syndrome (MS) is a term that identifies an aggregate of physiological abnormalities which increases the risk of liver disease, type 2 diabetes (T2D), and cardiovascular disease (Agyemang-Yeboah, Eghan, Annani-Akollor, Togbe, Donkor, & Afranie, 2019). Physiological abnormalities that constitute MS include dysregulated glucose metabolism, high blood pressure, abdominal obesity, and abnormal lipid profiles (Agyemang-Yeboah et […]
Read MoreDigestion and absorption processes occurs along the entirety of the gastrointestinal tract (GIT) and demands participation of several physiological and biochemical events at each segment. In my last posts, I considered optimal functioning of accessory organs (i.e., liver, pancreas), their secretions, optimal acidity, as well as intestinal lining and its relationship to immune health and […]
Read MoreThe gastrointestinal tract (GIT) is an estimated 16-foot long system, which includes the upper digestive tract (esophagus, oral cavity, stomach) in addition to the lower digestive tract (small and large intestine) and accessory organs (liver, gallbladder, pancreas) (Gropper, Smith, & Carr, 2018). Such a system serves as a semipermeable gateway connecting the outside environment to […]
Read MoreGastroesophageal reflux disease (GERD) is a common condition affecting as much as 48% of Westernized countries (Ebrahimi-Mameghani, Sabour, Khoshbaten, Arefhosseini, & Saghafi-Asl, 2017). Such a health problem, left unmanaged, can lead to and produce other conditions such as gastrointestinal bleeding and esophageal stricture (narrowing). Thus, detection and management of said condition is paramount. As a […]
Read MoreIn this author’s last post, low stomach acidity (high pH), micronutrient maldigestion/malabsorption, causes/symptoms of high pH, and solutions to mitigate such conditions were considered. However, low stomach acidity can induce systemic affects where other physiological disruptions occur along the gastrointestinal (GI) tract, to include gut dysbiosis (Pizzorno & Katzinger, 2012). As such, the following will […]
Read More